Falcon Point Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-49,987
Closed -$2.41M 127
2019
Q2
$2.41M Sell
49,987
-5,632
-10% -$296K 1.29% 34
2019
Q1
$3.48M Sell
55,619
-28,099
-34% -$1.93M 1.9% 22
2018
Q4
$5M Sell
83,718
-113,167
-57% -$6.79M 2.99% 5
2018
Q3
$12.7M Sell
196,885
-37,110
-16% -$2.07M 2.73% 9
2018
Q2
$10.5M Sell
233,995
-74,121
-24% -$2.96M 2.07% 15
2018
Q1
$9.57M Buy
308,116
+265,468
+622% +$8.73M 1.91% 23
2017
Q4
$1.27M Sell
42,648
-20,673
-33% -$599K 0.22% 64
2017
Q3
$1.84M Sell
63,321
-3,270
-5% -$113K 0.27% 56
2017
Q2
$2.23M Sell
66,591
-9,442
-12% -$282K 0.3% 53
2017
Q1
$2.2M Sell
76,033
-30,930
-29% -$766K 0.29% 54
2016
Q4
$2.39M Buy
106,963
+4,051
+4% +$79.2K 0.32% 51
2016
Q3
$1.82M Sell
102,912
-15,741
-13% -$297K 0.28% 52
2016
Q2
$1.93M Sell
118,653
-14,270
-11% -$210K 0.33% 55
2016
Q1
$1.55M Buy
132,923
+70,371
+113% +$786K 0.27% 59
2015
Q4
$731K Buy
+62,552
New +$791K 0.16% 76

Other funds holding BEAT

Falcon Point Capital's BEAT Position: Q3 2019 in Review

Falcon Point Capital sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 49,987 shares — an estimated $2.41M sold.

Falcon Point Capital first reported a position in BEAT in Q4 2015 and held it in 15 quarters. The position peaked at $12.7M in Q3 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Falcon Point Capital reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • Falcon Point Capital sold 49,987 BioTelemetry, Inc. shares in Q3 2019, an estimated $2.41M.
  • Falcon Point Capital first reported a position in BioTelemetry, Inc. in Q4 2015 and held it in 15 quarters.
  • Falcon Point Capital's BioTelemetry, Inc. position peaked at $12.7M in Q3 2018.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Falcon Point Capital's 13F filing for Q3 2019, filed 13 Nov 2019.